TrialNeurosurgery2017

Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial.

Maged D Fam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.